Key result
Serum anti-M2-R levels were higher in patients with long-standing persistent AF compared to non-AF controls and correlated with atrial fibrosis severity.
Why the study?
To investigate the association of serum autoantibodies against M2-muscarinic acetylcholine receptor with atrial fibrosis in long-standing persistent AF patients.
Are serum anti-M2-R levels associated with atrial fibrosis in patients with long-standing persistent atrial fibrillation?
Observational (n=50)
Are serum anti-M2-R levels associated with atrial fibrosis in patients with long-standing persistent atrial fibrillation?
Serum anti-M2-R levels are elevated in patients with long-standing persistent AF and correlate positively with the severity of atrial fibrosis.
Answers are grounded in this paper and cite their sources.
Anti-M2-R elevation was associated with fibrosis severity in long-standing persistent AF; hypothesis-generating, requires prospective validation before clinical consideration.
Objectives . To investigate the association of serum autoantibodies against M2-muscarinic acetylcholine receptor (anti-M2-R) with atrial fibrosis in long-standing persistent atrial fibrillation (AF) patients. Methods . Twenty-four long-standing persistent AF patients, scheduled to undergo hybrid ablation surgery, were enrolled in the study. Twenty-six patients with sinus rhythm, scheduled to undergo coronary artery bypass grafting surgery, were enrolled into the non-AF group. We detected serum anti-M2-R levels. Left atrial appendages were subjected to histological and molecular biological assays. Patients in the AF group received follow-up for two years. Results . The AF group showed significantly higher serum anti-M2-R levels compared to the non-AF group (496.2 ± 232.5 vs. 86.3 ± 25.7 pmol/L, p<0.001). The AF group exhibited severe fibrosis in the left atrial appendages, as indicated by increased collagen volume fraction (45.2 ± 4.7% vs. 27.6 ± 8.3%, p<0.001), and higher levels of collagen I (0.52 ± 0.04 vs. 0.24 ± 0.06, p<0.001) and collagen III (0.51 ± 0.07 vs. 0.36 ± 0.09, p<0.001). TGF- β 1 and CTGF were also upregulated in the AF group. A positive correlation between serum anti-M2-R levels and fibrosis of the left atrial appendage and fibrogenic indexes was observed. Conclusions . Serum anti-M2-R levels are higher in AF patients and are associated with the severity of atrial fibrosis. In addition, serum anti-M2-R levels are positively correlated to TGF- β 1 and CTGF expression in the left atrial appendage.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2019) conducted an observational in Long-standing persistent atrial fibrillation (n=50). Long-standing persistent atrial fibrillation vs. Sinus rhythm (non-AF group) was evaluated on Serum anti-M2-R levels (pmol/L) (p=<0.001). Serum anti-M2-R levels were higher in patients with long-standing persistent AF compared to non-AF controls and correlated with atrial fibrosis severity.
Synapse has enriched 10 related papers. Consider them for comparative context: